Physician profile
Rafi S Bidros
NPI 1932373073
$12,254.97
in general payments reported to CMS, 2019-2025
28 companies · $3,020 in 2025
The $3,020 reported for 2025 was more than what 88% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,131 · 2020: $1,254 · 2021: $2,674 · 2022: $856 · 2023: $602 · 2024: $718 · 2025: $3,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,853 · Travel and Lodging: $703 · Long Term Medical Supply Or Device Loan: $652 · Gift: $87.00 · Education: $44.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,853.06 |
| Travel and Lodging | $703.32 |
| Long Term Medical Supply Or Device Loan | $651.60 |
| Gift | $87.00 |
| Education | $44.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,174.68 | 2019-2022 | |
| Motiva USA, LLC | $1,508.00 | 2025 | |
| Mentor Worldwide LLC | $1,250.71 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $802.00 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Sientra, INC. | $692.16 | 2019-2021 | |
| Davol INC. | $670.10 | 2019-2025 | Phasix Mesh |
| Tepha INC | $580.35 | 2020 | |
| Rti Surgical, INC | $358.85 | 2022-2025 | |
| Abbvie INC. | $319.71 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Axogen | $201.86 | 2023-2025 | Avance Nerve Graft |
| Zimmer Biomet Holdings, INC. | $196.81 | 2019-2020 | |
| Medline Industries LP | $163.22 | 2019 | |
| Abbott Laboratories | $160.25 | 2022 | |
| Galderma Laboratories, L.P. | $142.87 | 2019-2023 | |
| Baxter Healthcare | $136.17 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $135.32 | 2020-2025 | Onetrac Lx, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Revance Therapeutics, INC. | $103.29 | 2024-2025 | Daxxify |
| W. L. Gore & Associates, INC. | $87.16 | 2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial |
| Pacira Pharmaceuticals Incorporated | $86.61 | 2021-2023 | Exparel |
| Alafair Biosciences, INC. | $74.79 | 2024-2025 | Versawrap |
| Merz North America, INC. | $73.30 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $70.55 | 2019 | |
| Medtronic, INC. | $57.33 | 2023 | Swiftset |
| Tela Bio, INC. | $50.75 | 2020-2024 | Ovitex 2s |
| Polarityte, INC. | $50.00 | 2021 | |
| Stryker Corporation | $40.58 | 2019 | |
| Bard Peripheral Vascular, INC. | $40.27 | 2021 | |
| Biom'Up France Sas | $27.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafi Bidros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.